Company profile for Newave Pharmaceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Newave Pharmaceutical is a clinical-stage company focused on developing innovative treatments for hematological malignancies and autoimmune diseases. Targeting clinically validated pathways like BTK, Bcl-2, and Bcl-xL, Newave advances multi-center clinical programs globally. Its lead candidates?LP-168 (Rocbrutinib), LP-108 (Lacutoclax), and LP-118?have shown strong efficacy and safety, with Rocbrutinib and Lacutoclax approved ...
Newave Pharmaceutical is a clinical-stage company focused on developing innovative treatments for hematological malignancies and autoimmune diseases. Targeting clinically validated pathways like BTK, Bcl-2, and Bcl-xL, Newave advances multi-center clinical programs globally. Its lead candidates?LP-168 (Rocbrutinib), LP-108 (Lacutoclax), and LP-118?have shown strong efficacy and safety, with Rocbrutinib and Lacutoclax approved by China?s NMPA for pivotal trials. Newave is committed to becoming a multinational leader in addressing unmet medical needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4695 Chabot Drive Suite 200, Pleasanton 94588
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty